Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
K M Laurence, N James, M H Miller, G B Tennant, H Campbell, K M Laurence, N James, M H Miller, G B Tennant, H Campbell
Abstract
A randomized controlled double-blind trial was undertaken in south Wales to prevent the recurrence of neural-tube defects in women who had had one child with a neural-tube defect. Sixty women were allocated before conception to take 4 mg of folic acid a day before and during early pregnancy and 44 complied with these instructions. Fifty-one women were allocated to placebo treatment. There were no recurrences among the compliant mothers but two among the non-compliers and four among the women in the placebo group. Thus there were no recurrences among those who received supplementation and six among those who did not; this difference is significant (p = 0.04). It is concluded that folic acid supplementation might be a cheap, safe, and effective method of primary prevention of neural-tube defects but that this must be confirmed in a large, multicentre trial.
References
- J Clin Pathol. 1966 Jan;19(1):17-28
- Br J Prev Soc Med. 1968 Jul;22(3):146-60
- Br J Prev Soc Med. 1968 Oct;22(4):212-22
- Am J Obstet Gynecol. 1952 Jun;63(6):1298-304
- Arch Dis Child. 1976 Dec;51(12):944-50
- Lancet. 1980 Feb 16;1(8164):339-40
- Med Lab Technol. 1972 Apr;29(2):171-81
Source: PubMed